Keller N - Search Results

1

Intracellular survival of persistent group A streptococci in cultured epithelial cells.

Marouni MJ, Barzilai A, Keller N, Rubinstein E, Sela S. Marouni MJ, et al. Among authors: keller n. Int J Med Microbiol. 2004 Jul;294(1):27-33. doi: 10.1016/j.ijmm.2004.01.001. Int J Med Microbiol. 2004. PMID: 15293451

2

Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers.

Neeman R, Keller N, Barzilai A, Korenman Z, Sela S. Neeman R, et al. Among authors: keller n. Lancet. 1998 Dec 19-26;352(9145):1974-7. doi: 10.1016/S0140-6736(97)12452-7. Lancet. 1998. PMID: 9872247 Clinical Trial.

3

The susceptibility of Streptococcus pneumoniae to levofloxacin and other antibiotics.

Keller N, Smollen G, Davidson Y, Barzilai A, Keren G, Rubinstein E. Keller N, et al. J Antimicrob Chemother. 1999 Jun;43 Suppl C:1-3. doi: 10.1093/jac/43.suppl_3.1. J Antimicrob Chemother. 1999. PMID: 10404329

4

Future prospects and therapeutic potential of streptogramins.

Rubinstein E, Keller N. Rubinstein E, et al. Among authors: keller n. Drugs. 1996;51 Suppl 1:38-42. doi: 10.2165/00003495-199600511-00008. Drugs. 1996. PMID: 8724815 Review.

5

Pseudomonas aeruginosa bacteremia in children: analysis of trends in prevalence, antibiotic resistance and prognostic factors.

Grisaru-Soen G, Lerner-Geva L, Keller N, Berger H, Passwell JH, Barzilai A. Grisaru-Soen G, et al. Among authors: keller n. Pediatr Infect Dis J. 2000 Oct;19(10):959-63. doi: 10.1097/00006454-200010000-00003. Pediatr Infect Dis J. 2000. PMID: 11055596

6

The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.

Rubinstein E, Diamantstein L, Yoseph G, Gruzman G, Rubinovitch B, Barzilai A, Keller N. Rubinstein E, et al. Among authors: keller n. Clin Microbiol Infect. 2000 Dec;6(12):678-81. doi: 10.1046/j.1469-0691.2000.00166.x. Clin Microbiol Infect. 2000. PMID: 11284929 Free article. No abstract available.

7

Spiramycin renaissance.

Rubinstein E, Keller N. Rubinstein E, et al. Among authors: keller n. J Antimicrob Chemother. 1998 Nov;42(5):572-6. doi: 10.1093/jac/42.5.572. J Antimicrob Chemother. 1998. PMID: 9848439 Review. No abstract available.

8

Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients.

Barzilai A, Rubinovich B, Blank-Porat D, Rubinstein E, Keller N, Levi I. Barzilai A, et al. Among authors: keller n. Scand J Infect Dis. 1998;30(2):143-6. doi: 10.1080/003655498750003528. Scand J Infect Dis. 1998. PMID: 9730300

9

Predictors of adverse outcome from candidal infection in a tertiary care hospital.

Ben-Abraham R, Keller N, Teodorovitch N, Barzilai A, Harel R, Barzilay Z, Paret G. Ben-Abraham R, et al. Among authors: keller n. J Infect. 2004 Nov;49(4):317-23. doi: 10.1016/j.jinf.2004.02.015. J Infect. 2004. PMID: 15474630

10

Invasive meningococcal disease: patient and strain characteristics set new challenge for prevention and control.

Paret G, Keller N, Barzilai A, Zemach M, Guttman D, Vardi A, Shatzberg G, Cohen H, Barzilay Z. Paret G, et al. Among authors: keller n. Infection. 1999;27(4-5):261-4. doi: 10.1007/s150100050025. Infection. 1999. PMID: 10885839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

963 results

Search Page

Filters